Adam Kovalčík , 19, receives $100,000 Top Award for his development of a medicine that can stop viruses from copying genes and controlling infections at the world's largest pre-college STEM competition in Columbus, Ohio

Prosecutors are proposing a nonprosecution agreement to resolve Boeing's violation of an earlier settlement.

Virgin Galactic Holdings Inc (NYSE:SPCE) shares surged almost 40% after the space travel company reported significant progress in its cost-cutting efforts during the first quarter. The company reduced its operating expenses by 21% year-over-year to $89 million, narrowing its net loss to $84 million or $2.38 per share compared to a loss of $102 million or loss per share of $5.10 in the year-ago quarter.

The gold market has been selling for most of the week, but there is still a bit of support underneath that could come into the picture and lift things.

Walmart tops earnings and revenue estimates but warns of price hikes.

Downgrading HWM to hold as valuation at 28x forward EBITDA now fully reflects near-term upside, making risk-reward less attractive. Strong Q1 results driven by aerospace spares and defense, with aftermarket sales boosting margins and long-term growth runway from F-35 spares. Industrial Gas Turbine segment benefits from global energy demand and AI/data center growth, with capacity expansions underway to capture more upside.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zenas To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of Zenas pursuant and/or traceable to Zenas' registration statement for the initial public offering held on or about September 13, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , May 16, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national …

I've exited my Telefonica position after years of solid returns, as the stock nears my $5/share price target and upside looks limited. Despite decent 1Q25 results and strong brands like VIVO and O2, organic revenue and B2C sales are showing negative trends. While Telefonica is meeting its own 2025 targets, negative free cash flow and rising churn in core markets concern me.

BA secures a contract from Qatar Airways for 210 widebody aircraft, including 130 787 Dreamliners and 30 777-9s aircraft.

GE HealthCare launches CleaRecon DL, an AI-powered 3D imaging tech that enhances cone-beam CT scans by reducing artifacts, improving clarity for better interventional care.

CSIQ's Q1 revenues beat the Zacks Consensus Estimate by 9.9%. However, the top line decreases 10% from the year-ago level.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=148912&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.

Lowe's, the second-largest home improvement retailer in the U.S., will soon report its Q1 earnings. In this article, I initiate my coverage of the stock, showing the macroeconomic environment and what the prospects for the company could be. While right now, a hold seems justified, there are reasons to look closely at the stock after earnings to consider it an opportunistic buy.

AMAT's Q2 fiscal 2025 results reflect strength in semiconductor systems, AGS, display and adjacent markets, offset by the decline in corporate and other revenues.

Media companies are considering options for their once lucrative cable TV businesses that are now in decline as millions of consumers pivot to streamers such as Netflix.

MAGNOLIA, Texas, May 16, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, announced its newest Houston-area community, Toll Brothers at Wildtree , is coming soon to Magnolia, Texas. This highly anticipated community will feature modern one- and two-story home designs on expansive 60-foot-wide home sites. Construction is underway, and sales are expected to begin in late 2025.

Bluerock Homes Trust's stock has sharply underperformed both the real estate sector and the S&P 500 YTD. But there are encouraging signs for the stock now. The company's revenue growth remains solid, with increases in average rent per occupied unit and higher occupancy rates. The REIT trades at an attractive price-to-core FFO compared with peers, and its recently initiated dividends also promise a robust yield.

I recommend a hold on ARR due to its attractive dividend yield balanced by risks from interest rate uncertainty and high leverage. Dividend coverage appears adequate short-term, but discrepancies between GAAP and non-GAAP earnings raise long-term sustainability concerns. ARR's financial performance is hindered by high leverage and interest rate sensitivity, limiting growth and increasing risk in current conditions.

ATA Creativity Global (NASDAQ:AACG ) Q1 2025 Earnings Conference Call May 16, 2025 9:00 PM ET Company Participants Alice Zhang - Investor Relations, The Equity Group Kevin Ma - Chairman and Chief Executive Officer Ruobai Sima - Chief Financial Officer Jun Zhang - President Operator Greetings. Welcome to the ATA Creativity Global First Quarter 2025 Financial Results Conference Call.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zynex To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Zynex between March 13, 2023 and March 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , May 16, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Zynex, Inc. ("Zynex" or …